
Stuart J. Pocock
Articles
-
Nov 21, 2024 |
academic.oup.com | Chris Gale |Cian P. McCarthy |Stuart J. Pocock |Gabrielle Freedman
This PDF is available to Subscribers OnlyFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
-
Jul 11, 2024 |
onlinecjc.ca | John Eikelboom |William F McIntyre |William Mcintyre |Jacqueline Bosch |Richard P. Whitlock |Qilong Yi | +6 more
Abstract Win ratio (WR) is a newer analytic approach for trials with composite endpoints that accounts for the relative importance of individual components. Our objective was to compare the results of the COMPASS trial analysed using WR compared with conventional statistical approaches.
-
Jun 2, 2024 |
jacc.org | John Gregson |Stuart J. Pocock |Stefan Anker |Deepak L. Bhatt
References1. "The analysis of survival data in nephrology: basic concepts and methods of Cox regression". Kidney Int . 2008;74:705-709. 2. "A proportional hazards model for the subdistribution of a competing risk". J Am Stat Assoc . 1999;94:496-509. 3. "Applying Cox regression to competing risks". Biometrics . 1995;51:524-532. 4. "Relaxing the independent censoring assumption in the Cox proportional hazards model using multiple imputation". Stat Med . 2014;33:4681-4694. 5. "R package InformativeCensoring.
-
Apr 1, 2024 |
dom-pubs.onlinelibrary.wiley.com | Khawaja M Talha |Jennifer Green |Gerasimos Filippatos |Stuart J. Pocock
CONFLICT OF INTEREST STATEMENT KMT has no conflicts of interest to declare. JG reports personal fees from Boehringer Ingelheim, Lilly, Bayer, Novo Nordisk, Pfizer, AstraZeneca, Sanofi, Hawthorne Effect, Omada Health, Vertex Pharmaceuticals, Valo Therapeutics and Anji Pharmaceuticals; receiving grants from Merck, Roche, Sanofi and Lexicon Pharmaceuticals.
-
Dec 18, 2023 |
bmjopen.bmj.com | Sibi N Krishnamurthy |Stuart J. Pocock |Prashant Kaul |Ruth Owen
AbstractObjectives Compared with ST-segment elevation myocardial infarction (STEMI) patients, non-STEMI (NSTEMI) patients have more comorbidities and extensive coronary artery disease. Contemporary comparative data on the long-term prognosis of stable post-myocardial infarction subtypes are needed. Design Long-Term rIsk, clinical manaGement and healthcare Resource utilisation of stable coronary artery dISease (TIGRIS) was a multinational, observational and longitudinal cohort study.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →